Ivivi extends forbearance on $2.5 million convertible through Sept. 21

By Devika Patel

Knoxville, Tenn., Sept. 17 - Ivivi Technologies, Inc. amended the terms of an Aug. 31 forbearance agreement negotiated with Emigrant Capital Corp., the holder of its $2.5 million convertible promissory note, according to an 8-K filed Thursday with the Securities and Exchange Commission.

Under the original agreement, the lender had agreed to let the company postpone paying the principal and interest due on the note until Sept. 14.

On Sept. 14, the parties agreed to extend the forbearance period through Sept. 16, and on Sept. 16 they amended the terms of the agreement to extend the forbearance period through Sept. 21.

Based in Northvale, N.J., Ivivi is a medical technology company focused on an electrotherapeutic technology platform.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.